tetano
Editor, Senior Moderator
mBio
. 2026 Apr 13:e0044526.
doi: 10.1128/mbio.00445-26. Online ahead of print.
Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies
Gagandeep Singh[SUP] 1 2 [/SUP], Disha Bhavsar[SUP] 1 2 [/SUP], Enikö Hermann[SUP] 3 [/SUP], Charles Gleason[SUP] 1 2 [/SUP], Harkirat Singh Sandhu[SUP] 1 2 [/SUP], Parul Singh[SUP] 1 2 [/SUP], Jessica R Nardulli[SUP] 1 2 [/SUP], Neko Lyttle[SUP] 1 2 [/SUP], Yuexing Chen[SUP] 1 2 [/SUP], Suzana Sabaiduc[SUP] 4 [/SUP], Garazi Peña Alzua[SUP] 1 2 [/SUP], Danuta M Skowronski[SUP] 4 5 [/SUP], Viviana Simon[SUP] 1 2 6 7 8 [/SUP], Florian Krammer[SUP] 1 2 3 6 9 [/SUP]
Affiliations
Clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses continue to expand geographically and across mammalian hosts, raising concern about pandemic potential. The degree and specificity of pre-existing immunity in humans are key determinants of this risk. We analyzed hemagglutinin (HA)- and neuraminidase (NA)-specific antibody responses in 300 sera collected from adults in New York City. While HA directed binding antibodies to clade 2.3.4.4b H5 were low and hemagglutination-inhibiting antibodies were absent, we detected widespread binding and functional NA antibodies against N1 neuraminidases from clade 2.3.4.4b H5N1 viruses. Neuraminidase inhibition (NI) titers were highest against North American D1.1 genotype N1 viruses and correlated strongly with neutralizing activity, whereas HA-binding antibodies did not. An additional N-linked glycosylation site, as found in the NA of a human D1.1 isolate from British Columbia, reduced susceptibility to NI antibodies. Antibodies titer to N5 from H5N5 were low to minimal. These findings indicate that population-level immunity to clade 2.3.4.4b H5 viruses is dominated by NA-directed antibodies, with important implications for pandemic risk assessment.IMPORTANCEUnderstanding how pre-existing human immunity shapes susceptibility to emerging influenza viruses is central to pandemic preparedness. Here, we determined that human sera contain widespread, functional antibodies targeting H5N1 neuraminidase, which correlate with virus neutralization, whereas HA-directed responses are limited. We further show that acquisition of an NA glycosylation site reduces antibody inhibition, highlighting a potential pathway for immune evasion. These results identify neuraminidase-specific immunity as a major immunological barrier to severe H5N1 disease in humans and emphasize the need to incorporate NA antigenicity into influenza surveillance, risk assessment, and next-generation vaccine design.
Keywords: B3.13; D1.1; H5N1; H5N5; avian influenza; clade 2.3.4.4b; neuraminidase.
. 2026 Apr 13:e0044526.
doi: 10.1128/mbio.00445-26. Online ahead of print.
Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies
Gagandeep Singh[SUP] 1 2 [/SUP], Disha Bhavsar[SUP] 1 2 [/SUP], Enikö Hermann[SUP] 3 [/SUP], Charles Gleason[SUP] 1 2 [/SUP], Harkirat Singh Sandhu[SUP] 1 2 [/SUP], Parul Singh[SUP] 1 2 [/SUP], Jessica R Nardulli[SUP] 1 2 [/SUP], Neko Lyttle[SUP] 1 2 [/SUP], Yuexing Chen[SUP] 1 2 [/SUP], Suzana Sabaiduc[SUP] 4 [/SUP], Garazi Peña Alzua[SUP] 1 2 [/SUP], Danuta M Skowronski[SUP] 4 5 [/SUP], Viviana Simon[SUP] 1 2 6 7 8 [/SUP], Florian Krammer[SUP] 1 2 3 6 9 [/SUP]
Affiliations
- PMID: 41972807
- DOI: 10.1128/mbio.00445-26
Clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses continue to expand geographically and across mammalian hosts, raising concern about pandemic potential. The degree and specificity of pre-existing immunity in humans are key determinants of this risk. We analyzed hemagglutinin (HA)- and neuraminidase (NA)-specific antibody responses in 300 sera collected from adults in New York City. While HA directed binding antibodies to clade 2.3.4.4b H5 were low and hemagglutination-inhibiting antibodies were absent, we detected widespread binding and functional NA antibodies against N1 neuraminidases from clade 2.3.4.4b H5N1 viruses. Neuraminidase inhibition (NI) titers were highest against North American D1.1 genotype N1 viruses and correlated strongly with neutralizing activity, whereas HA-binding antibodies did not. An additional N-linked glycosylation site, as found in the NA of a human D1.1 isolate from British Columbia, reduced susceptibility to NI antibodies. Antibodies titer to N5 from H5N5 were low to minimal. These findings indicate that population-level immunity to clade 2.3.4.4b H5 viruses is dominated by NA-directed antibodies, with important implications for pandemic risk assessment.IMPORTANCEUnderstanding how pre-existing human immunity shapes susceptibility to emerging influenza viruses is central to pandemic preparedness. Here, we determined that human sera contain widespread, functional antibodies targeting H5N1 neuraminidase, which correlate with virus neutralization, whereas HA-directed responses are limited. We further show that acquisition of an NA glycosylation site reduces antibody inhibition, highlighting a potential pathway for immune evasion. These results identify neuraminidase-specific immunity as a major immunological barrier to severe H5N1 disease in humans and emphasize the need to incorporate NA antigenicity into influenza surveillance, risk assessment, and next-generation vaccine design.
Keywords: B3.13; D1.1; H5N1; H5N5; avian influenza; clade 2.3.4.4b; neuraminidase.